AZENTA, INC. (AZTA) FY2026 Q3 Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
AZENTA, INC. (AZTA) FY2026 Q3 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current assets$681.35 MCurrent liabilities$272.57 MAssets$1.88 BLiabilities$366.08 MEquity$1.51 BNon-current liabilities$93.51 MNon-current assets$1.19 BGross equity(calculated)$1.74 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, net of allowance for expected credit losses ($3,842 and $4,649, respectively)Short-term marketable securitiesInventoriesCurrent assets held for salePrepaid expenses and other current assetsRefundable income taxesShort-term restricted cashGoodwillLong-term marketable securitiesProperty, plant and equipment, netIntangible assets, netNoncurrent assets held for saleOperating lease right-of-use assetsLong-term income taxes receivableOther assetsLong-term deferred tax assetsAccounts payableDeferred revenueCustomer depositsAccrued expenses and other current liabilitiesAccrued compensation and benefitsCurrent liabilities held for saleDerivative liabilityDeposit received for the sale of B Medical Systems businessAccrued income taxes payableAccrued warranty and retrofit costsLong-term operating lease liabilitiesLong-term deferred tax liabilitiesNoncurrent liabilities held for saleOther long-term liabilitiesRetained earningsAdditional paid-in capitalCommon stock, $0.01 par value - 125,000,000 shares authorized, 57,226,616 shares issued and 43,764,747 shares outstanding at June 30, 2026; 59,320,848 shares issued and 45,858,979 shares outstanding at September 30, 2025Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost - 13,461,869 shares at June 30, 2026 and September 30, 2025Accumulated other comprehensive lossAccounts payableAccounts payable$39.38 MDeferred revenueDeferred revenue$36.04 MCash and cash equivalentsCash and cash equivalents$189.65 MCustomer depositsCustomer deposits$35.36 MAccounts receivable, net of allowance for expected credit losses ($3,842 and $4,649, respectively)Accounts receivable, net$143.68 MAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$34.25 MCurrent assetsCurrent assets$681.35 MCurrent liabilitiesCurrent liabilities$272.57 MAccrued compensation and benefitsAccrued compensation and benefits$30.97 MShort-term marketable securitiesShort-term marketable securities$136.14 MCurrent liabilities held for saleCurrent liabilities held for sale$29.33 MInventoriesInventories$79.08 MDerivative liabilityDerivative liability$28.44 MCurrent assets held for saleCurrent assets held for sale$71.39 MAssetsAssets$1.88 BLiabilitiesLiabilities$366.08 MDeposit received for the sale of B Medical Systems businessDeposit received for the saleof B Medical Systems business$28.00 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$53.15 MRefundable income taxesRefundable income taxes$5.85 MAccrued income taxes payableAccrued income taxes payable$6.78 MShort-term restricted cashShort-term restricted cash$2.41 MAccrued warranty and retrofit costsAccrued warranty and retrofit costs$4.05 MEquityEquity$1.51 BLong-term operating lease liabilitiesLong-term operating lease liabilities$53.97 MGoodwillGoodwill$547.46 MNon-current liabilitiesNon-current liabilities$93.51 MLong-term deferred tax liabilitiesLong-term deferred tax liabilities$15.84 MNon-current assetsNon-current assets$1.19 BNoncurrent liabilities held for saleNoncurrent liabilities held for sale$12.98 MLong-term marketable securitiesLong-term marketable securities$196.09 MOther long-term liabilitiesOther long-term liabilities$10.73 MProperty, plant and equipment, netProperty, plant and equipment, net$172.43 MGross equity (calculated)Gross equity(calculated)$1.74 BIntangible assets, netIntangible assets, net$85.69 MNoncurrent assets held for saleNoncurrent assets held for sale$76.69 MRetained earningsRetained earnings$1.25 BOperating lease right-of-use assetsOperating lease right-of-use assets$61.42 MLong-term income taxes receivableLong-term income taxes receivable$45.60 MOther assetsOther assets$9.00 MLong-term deferred tax assetsLong-term deferred tax assets$494.00 KAdditional paid-in capitalAdditional paid-in capital$493.07 MCommon stock, $0.01 par value - 125,000,000 shares authorized, 57,226,616 shares issued and 43,764,747 shares outstanding at June 30, 2026; 59,320,848 shares issued and 45,858,979 shares outstanding at September 30, 2025Common stock$572.00 KTreasury stock, at cost - 13,461,869 shares at June 30, 2026 and September 30, 2025Treasury stock−$200.96 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$28.74 M
Chart details

AZENTA, INC. (AZTA) FY2026 Q3 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
1,876,211,000 US dollars
Current assets
681,351,000 US dollars
Non-current assets
1,194,860,000 US dollars
Liabilities
366,082,000 US dollars
Current liabilities
272,574,000 US dollars
Non-current liabilities
93,508,000 US dollars
Equity
1,510,129,000 US dollars
Cash and cash equivalents
189,654,000 US dollars
Accounts receivable, net of allowance for expected credit losses ($3,842 and $4,649, respectively)
143,675,000 US dollars
Short-term marketable securities
136,143,000 US dollars
Inventories
79,082,000 US dollars
Current assets held for sale
71,387,000 US dollars
Prepaid expenses and other current assets
53,150,000 US dollars
Refundable income taxes
5,846,000 US dollars
Short-term restricted cash
2,414,000 US dollars
Goodwill
547,457,000 US dollars
Long-term marketable securities
196,087,000 US dollars
Property, plant and equipment, net
172,427,000 US dollars
Intangible assets, net
85,688,000 US dollars
Noncurrent assets held for sale
76,689,000 US dollars
Operating lease right-of-use assets
61,421,000 US dollars
Long-term income taxes receivable
45,600,000 US dollars
Other assets
8,997,000 US dollars
Long-term deferred tax assets
494,000 US dollars
Accounts payable
39,381,000 US dollars
Deferred revenue
36,041,000 US dollars
Customer deposits
35,355,000 US dollars
Accrued expenses and other current liabilities
34,249,000 US dollars
Accrued compensation and benefits
30,965,000 US dollars
Current liabilities held for sale
29,326,000 US dollars
Derivative liability
28,435,000 US dollars
Deposit received for the sale of B Medical Systems business
28,000,000 US dollars
Accrued income taxes payable
6,775,000 US dollars
Accrued warranty and retrofit costs
4,047,000 US dollars
Long-term operating lease liabilities
53,967,000 US dollars
Long-term deferred tax liabilities
15,836,000 US dollars
Noncurrent liabilities held for sale
12,980,000 US dollars
Other long-term liabilities
10,725,000 US dollars
Retained earnings
1,246,182,000 US dollars
Additional paid-in capital
493,071,000 US dollars
Common stock, $0.01 par value - 125,000,000 shares authorized, 57,226,616 shares issued and 43,764,747 shares outstanding at June 30, 2026; 59,320,848 shares issued and 45,858,979 shares outstanding at September 30, 2025
572,000 US dollars
Preferred stock, $0.01 par value - 1,000,000 shares authorized, no shares issued or outstanding
0 US dollars
Treasury stock, at cost - 13,461,869 shares at June 30, 2026 and September 30, 2025
negative 200,956,000 US dollars
Accumulated other comprehensive loss
negative 28,740,000 US dollars
Gross equity (calculated)
1,739,825,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
AZENTA, INC. (AZTA) FY2026 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!